General Electric is reevaluating plans for an IPO for its health-care unit following the sale of its biopharma business, CEO Larry Culp told CNBC on Monday. An IPO for GE Healthcare this year is now in doubt, Culp said. Earlier reports incorrectly suggested the plans were off the table.
Trending:
GE reevaluating plans for Healthcare IPO after Danaher deal